Cancer "photo-chemoprevention" with pulsed dye laser and celecoxib

Lasers in Surgery and Medicine

Volumn 32, Issue 3, 2003, Pages 180-184

  Wang, Zhi ^a,b   Fuentes, Cesar F ^a   Shapshay, Stanley M ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Dept Otolaryngol Head/Neck Surg ^*  (United States)

Author keywords

Cancer; Celecoxib; Chemoprevention; Laser; Mouse

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER LOCALIZATION; CANCER PHOTOCHEMOPREVENTION; CANCER PREVENTION; CANCER RADIOTHERAPY; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MOUSE; MOUTH CANCER; NONHUMAN; PRIORITY JOURNAL; PULSED DYE LASER;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CHEMOPREVENTION; COMBINED MODALITY THERAPY; DISEASE MODELS, ANIMAL; LASERS; MICE; MICE, NUDE; MOUTH NEOPLASMS; NEOPLASM TRANSPLANTATION; PROBABILITY; PYRAZOLES; RANDOM ALLOCATION; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SULFONAMIDES; TREATMENT OUTCOME;

EID: 0037237743     PISSN: 01968092     EISSN: None     Source Type: Journal    
DOI: 10.1002/lsm.10147     Document Type: Article

References (23)

1. Wingo PA, Tong T, Bolden S. Cancer statistics. Ca Cancer J Clin 1995;45:8-30.
2. Hong WK, Lippamn SM, Itri LM, Karp DD. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med 1990;323:785-801.
3. Papadimitrakopoulou V, Hong WK. Retinoids in head and neck chemoprevention. Proc Soc Exp Biol Med 1997;216:283-290.
4. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other diseases. Nat Med 1995;1:27-31.
5. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996;86: 353-364.
6. McMillan K, Perepelitsyn I, Wang Z, Shapshay SM. Tumor growth inhibition and regression induced by photothermal vascular targeting and angiogenesis inhibitor retinoic acid. Cancer Lett 1999;137:35-44.
7. Taketo MM. Cyclooxygenase-2 inhibitor in tumorigenesis (Part I). J Nat Cancer Inst 1998;90:1529-1536.
8. Kawamori T, Rao CV, Seihbert K, Reddy BS. Chemopreventive activity of Celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res 1998;58:409-412.
9. Kelloff GJ. Perspectives on cancer chemoprevention research and drug development. Advance Cancer Res 2000;78:200-234.
10. McMillan K, Wang Z, Shapshay SM. Inhibition and regression of tumors in hamster-DMBA model following laser microvasular targeting. Proc SPIE 1998;3245:149-160.
11. McMillan K, Shapshay SM, McGilligan JA, Wang Z, Rebeiz EE. A 585 nanometer pulsed dye laser treatment of laryngeal papillomas, preliminary report. Laryngoscope 1998;108:968-972.
12. Hong WK, Sporn MB. Recent advances in chemoprevention of cancer. Science 1997;278:1073-1077.
13. Shah R, Valdez T, Wang Z, Shapshay SM. Pulsed dye laser and retinoic acid delay progression of oral squamous cell carcinoma in a nurine model. Laryngoscope 2001;111:1203-1208.
14. Pendlant A, Schoggins SJ, Scott GA, Khan KN, Han R. Reduction of NU-induced skin tumors in hairless mice by selective COX-2 inhibition. Carcinogenesis 1999;20:1939-1944.
15. Kawamori T, Rao CV, Seihbert K, Reddy BS. Chemopreventive activity of Celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res 1998;58:409-412.
16. Nishimura G, Yanoma S, Mizuno H, Kawakami K, Tsukuda M. A selective cyclooxygenase-2 inhibitor suppresses tumor growth in nude mouse xenografted with human head and neck squamous carcinoma cells. Jpn J Cancer Res 1999;90: 1152-1162.
17. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX2). Cell 1996;87:803-809.
18. Lingen MW, Polverini PJ, Bouch NP. Retinoic acid and interferon act synergistically as antiangiogenic and antitumor agents against human head and neck squamous. Cancer Res 1998;58:5551-5558.
19. Masterrer JL, Leahy KM, Koki AT, Zweifel BS. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res 2000;60:1306-1311.
20. Kenyon BM, Voest EE, Chen CC, Flynn E, Folkman J, DAmato RJ. A model of angiogenesis in the mouse cornea. Invest Ophthalmol Vis Sci 1996;37:1625-1632.
21. Chan G, Boyle JO, Yang EK, Zhang F. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res 1999;59:991-994.
22. Wang Z, Fuentes CF, Shapshay SM. Anti-angiogenic and chemopreventive activities of Celecoxib in oral carcinoma cell. Laryngoscope 2002;112:839-843.
23. Goldstein JL, Silverstein FE, Agrawal NM. Reduced risk of upper gastrointestinal ulcer complications with Celecoxib, a novel COX-2 inhibitor. Am J Gastroenterol 2000;95:1681-1690.